These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38385826)

  • 41. Clinical analysis of
    Feng W; Fang F; Wang X; Chen C; Lu J; Deng J
    Pediatr Investig; 2022 Jun; 6(2):93-99. PubMed ID: 35774528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mosaic microdeletion of 17p11.2-p12 and duplication of 17q22-q24 in a girl with Smith-Magenis phenotype and peripheral neuropathy.
    Goh ES; Banwell B; Stavropoulos DJ; Shago M; Yoon G
    Am J Med Genet A; 2014 Mar; 164A(3):748-52. PubMed ID: 24357149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel de novo frameshift variant in the CHD2 gene related to intellectual and developmental disability, seizures and speech problems.
    Mir A; Song Y; Lee H; Nadeali Z; Tabatabaiefar MA
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2305. PubMed ID: 37877434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Case report: Deep sequencing and long-read genome sequencing refine prior genetic analyses in families with apparent gonadal mosaicism in
    Orellana H; Yan J; Paul A; Tokita M; Ding Y; Ghosh R; Lewis KL; Davis J; Jamal L; Jodarski C; Similuk M; Saucier N; Zhu Z; Wang Y; Wu S; Ruggieri J; Su HC; Uzel G; Nahas S; Cooper M; Walkiewicz MA
    Front Immunol; 2024; 15():1451212. PubMed ID: 39253077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RAI1 point mutations, CAG repeat variation, and SNP analysis in non-deletion Smith-Magenis syndrome.
    Bi W; Saifi GM; Girirajan S; Shi X; Szomju B; Firth H; Magenis RE; Potocki L; Elsea SH; Lupski JR
    Am J Med Genet A; 2006 Nov; 140(22):2454-63. PubMed ID: 17041942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders.
    Campbell IM; Yuan B; Robberecht C; Pfundt R; Szafranski P; McEntagart ME; Nagamani SC; Erez A; Bartnik M; Wiśniowiecka-Kowalnik B; Plunkett KS; Pursley AN; Kang SH; Bi W; Lalani SR; Bacino CA; Vast M; Marks K; Patton M; Olofsson P; Patel A; Veltman JA; Cheung SW; Shaw CA; Vissers LE; Vermeesch JR; Lupski JR; Stankiewicz P
    Am J Hum Genet; 2014 Aug; 95(2):173-82. PubMed ID: 25087610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures.
    Thomas RH; Zhang LM; Carvill GL; Archer JS; Heavin SB; Mandelstam SA; Craiu D; Berkovic SF; Gill DS; Mefford HC; Scheffer IE;
    Neurology; 2015 Mar; 84(9):951-8. PubMed ID: 25672921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Smith-Kingsmore syndrome: A third family with the MTOR mutation c.5395G>A p.(Glu1799Lys) and evidence for paternal gonadal mosaicism.
    Moosa S; Böhrer-Rabel H; Altmüller J; Beleggia F; Nürnberg P; Li Y; Yigit G; Wollnik B
    Am J Med Genet A; 2017 Jan; 173(1):264-267. PubMed ID: 27753196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gonadal mosaicism of large terminal de novo duplication and deletion in siblings with variable intellectual disability phenotypes.
    Rahman MM; Uddin KF; Al Jezawi NK; Karuvantevida N; Akter H; Dity NJ; Rahaman MA; Begum M; Rahaman MA; Baqui MA; Salwa Z; Islam S; Woodbury-Smith M; Basiruzzaman M; Uddin M
    Mol Genet Genomic Med; 2019 Oct; 7(10):e00954. PubMed ID: 31475484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes.
    Mullegama SV; Pugliesi L; Burns B; Shah Z; Tahir R; Gu Y; Nelson DL; Elsea SH
    Eur J Hum Genet; 2015 Jun; 23(6):781-9. PubMed ID: 25271084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parental mosaicism in another case of Dravet syndrome caused by a novel SCN1A deletion: a case report.
    Sharkia R; Hengel H; Schöls L; Athamna M; Bauer P; Mahajnah M
    J Med Case Rep; 2016 Mar; 10():67. PubMed ID: 27021235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of Sleep Disturbances Associated with Smith-Magenis Syndrome.
    Kaplan KA; Elsea SH; Potocki L
    CNS Drugs; 2020 Jul; 34(7):723-730. PubMed ID: 32495322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of parental mosaicism in
    de Lange IM; Koudijs MJ; van 't Slot R; Sonsma ACM; Mulder F; Carbo EC; van Kempen MJA; Nijman IJ; Ernst RF; Savelberg SMC; Knoers NVAM; Brilstra EH; Koeleman BPC
    J Med Genet; 2019 Feb; 56(2):75-80. PubMed ID: 30368457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel patient with White-Sutton syndrome refines the mutational and clinical repertoire of the POGZ-related phenotype and suggests further observations.
    Pascolini G; Agolini E; Fleischer N; Gulotta E; Cesario C; D'Elia G; Novelli A; Majore S; Grammatico P
    Am J Med Genet A; 2020 Jul; 182(7):1791-1795. PubMed ID: 32359026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Smith Magenis syndrome: First case of congenital heart defect in a patient with Rai1 mutation.
    Onesimo R; Delogu AB; Blandino R; Leoni C; Rosati J; Zollino M; Zampino G
    Am J Med Genet A; 2022 Jul; 188(7):2184-2186. PubMed ID: 35373511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems.
    Chénier S; Yoon G; Argiropoulos B; Lauzon J; Laframboise R; Ahn JW; Ogilvie CM; Lionel AC; Marshall CR; Vaags AK; Hashemi B; Boisvert K; Mathonnet G; Tihy F; So J; Scherer SW; Lemyre E; Stavropoulos DJ
    J Neurodev Disord; 2014; 6(1):9. PubMed ID: 24834135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homozygous TBC1D24 mutation in two siblings with familial infantile myoclonic epilepsy (FIME) and moderate intellectual disability.
    Poulat AL; Ville D; de Bellescize J; André-Obadia N; Cacciagli P; Milh M; Villard L; Lesca G
    Epilepsy Res; 2015 Mar; 111():72-7. PubMed ID: 25769375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mosaicism in ATP1A3-related disorders: not just a theoretical risk.
    Hully M; Ropars J; Hubert L; Boddaert N; Rio M; Bernardelli M; Desguerre I; Cormier-Daire V; Munnich A; de Lonlay P; Reilly L; Besmond C; Bahi-Buisson N
    Neurogenetics; 2017 Jan; 18(1):23-28. PubMed ID: 27726050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study on mosaicism of SCN1A gene mutation in parents of children with Dravet syndrome].
    Liu AJ; Yang XX; Xu XJ; Wu QX; Tian XJ; Yang XL; Wu XR; Wei LP; Zhang YH
    Zhonghua Er Ke Za Zhi; 2017 Nov; 55(11):818-823. PubMed ID: 29141311
    [No Abstract]   [Full Text] [Related]  

  • 60. Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2).
    Gropman AL; Duncan WC; Smith AC
    Pediatr Neurol; 2006 May; 34(5):337-50. PubMed ID: 16647992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.